HomeFUSN • NASDAQ
add
Fusion Pharmaceuticals Inc
Previous close
$21.46
Day range
$21.45 - $21.52
Year range
$2.31 - $21.58
Market cap
1.83B USD
Avg Volume
771.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 35.86M | 298.18% |
Net income | -33.67M | -38.61% |
Net profit margin | — | — |
Earnings per share | -0.40 | 11.11% |
EBITDA | -35.50M | -44.41% |
Effective tax rate | 0.70% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 210.52M | 0.32% |
Total assets | 323.81M | 21.48% |
Total liabilities | 81.98M | 24.75% |
Total equity | 241.83M | — |
Shares outstanding | 85.06M | — |
Price to book | 7.53 | — |
Return on assets | -29.41% | — |
Return on capital | -30.96% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -33.67M | -38.61% |
Cash from operations | -27.31M | -7.36% |
Cash from investing | -70.37M | -186.90% |
Cash from financing | 64.01M | 7.55% |
Net change in cash | -33.67M | -452.45% |
Free cash flow | -20.74M | -17.21% |
About
Founded
2014
Headquarters
Website
Employees
113